Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Cancer Research

• Publication date

  1991-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0162-0134(91)84573-RPMID 1516063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.

  1992cited by this paper
• Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.

  1992cited by this paper
• Activation of the trans geometry in platinum antitumor complexes. Synthesis, characterization, and biological activity of complexes with the planar ligands pyridine, N-methylimidazole, thiazole and quinoline. Crystal and molecular structure of trans-dichlorobis (thiazole)platinum(II)

  1992influential reference
• PHASE I TRIALS WITH ORMAPLATIN (TETRAPLATIN)

  1991cited by this paper
• Synthesis and Reactions of a New Class of Orally Active Pt(IV) Antitumor Complexes

  1991cited by this paper
• Reactivity of chloro- and aqua(diethylenetriamine)platinum(II) ions with glutathione, S-methylglutathione, and guanosine 5'-monophosphate in relation to the antitumor activity and toxicity of platinum complexes

  1991cited by this paper
• Characteristics of five human tumor cell lines and sublines resistant to cis‐diamminedichloroplatinum(II)

  1991cited by this paper
• The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.

  1991cited by this paper
• Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.

  1990cited by this paper
• Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair.

  1990cited by this paper
• Reaction of cis- and trans-[PtCl2(NH3)2] with reduced glutathione inside human red blood cells, studied by 1H and 15N-[1H] DEPT NMR.

  1990cited by this paper
• Reaction of cis- and trans-[PtCl2(NH3)2] with reduced glutathione studied by 1H, 13C, 195Pt and 15N-{1H} DEPT NMR

  1990cited by this paper
• Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.

  1990cited by this paper
• 195Pt NMR Kinetic and Mechanistic Studies of cis- and trans-Diamminedichloroplatinum(II) Binding to DNA.

  1990cited by this paper
• Chemical Properties and Antitumor Activity of Complexes of Platinum Containing Substituted Sulfoxides (PtCl(R′R′′SO)(diamine))NO3. Chirality and Leaving-Group Ability of Sulfoxide Affecting Biological Activity.

  1990cited by this paper
• Platinum—Amine Complexes as Anticancer Agents

  1989cited by this paper
• Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

  1989cited by this paper
• Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.

  1989cited by this paper
• Metal Antitumor Compounds: The Mechanism of Action of Platinum Complexes

  1989cited by this paper
• Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.

  1989influential reference
• Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro.

  1988cited by this paper
• Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.

  1988cited by this paper
• cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

  1988cited by this paper
• Overexpression of metallothionein confers resistance to anticancer drugs.

  1988cited by this paper
• Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione.

  1987cited by this paper
• Solvolysis Reactions of cis- and trans-Diamminedichloroplatinum(II) in Dimethyl Sulfoxide. Structural Characterization and DNA Binding of trans-(Pt(NH3)2(Me2SO)Cl)+.

  1987cited by this paper
• Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.

  1987cited by this paper
• Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.

  1987cited by this paper
• Platinum Coordination Complexes in Cancer Chemotherapy

  1984cited by this paper
• Actions of the rifamycins.

  1971cited by this paper
• Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro

  1970cited by this paper

• “Non-Classical” Platinum Complexes: A Concise Review

  2025cites this paper
• Novel Platinum(II) Tetrazine Complex Capable of Live‐Cell IEDDA Reaction

  2025cites this paper
• Fe-N carbon black oxide as catalysts for oxygen reduction reaction and application to room temperature direct lignin fuel cells

  2025cites this paper
• Structural variations in the trans-carboxylate/chlorido axis that impact the mode of action of Pt(ii) complexes

  2025cites this paper
• Efficient non-precious metal catalysts based on FePc-C60 for direct lignin fuel cells

  2025cites this paper
• Dibromo- and Dichlorotriphenylphosphino N-Acyclic Carbene Complexes of Platinum(II)—Synthesis and Cytotoxicity

  2023cites this paper
• Antitumor active trans‑platinum complexes through metabolic stability and enhanced cellular accumulation.

  2023cites this paper
• Synthesis and structure of two novel trans-platinum complexes

  2023cites this paper
• Synthesis, characterization and anticancer activities of Zn2+, Cu2+, Co2+ and Ni2+ complexes involving chiral amino alcohols

  2022cites this paper
• Synthesis and characterization of new platinum(II) complexes with cyclic iminoether-type ligands having the azomethine group out of cycle

  2021cites this paper
• A trans-dichloridoplatinum(II) complex of a monodentate nitrogen mustard: Synthesis, stability and cytotoxicity studies.

  2019cites this paper
• Biological relevance of interaction of platinum drugs with O-donor ligands.

  2019cites this paper
• Platinum(iv) dihydroxido diazido N-(heterocyclic)imine complexes are potently photocytotoxic when irradiated with visible light

  2019cites this paper
• Cobalt and copper complexes with formamidine ligands: Synthesis, crystal X-ray study, DFT calculations and cytotoxicity

  2019cites this paper
• Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies

  2019cites this paper
• trans-Platinum(II) Thionate Complexes: Synthesis, Structural Characterization, and in vitro Biological Assessment as Potent Anticancer Agents.

  2019cites this paper
• Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression

  2019cites this paper
• Cyclometallated platinum(IV) compounds as promising antitumour agents

  2019cites this paper
• Mass spectrometry as a powerful tool to study therapeutic metallodrugs speciation mechanisms: Current frontiers and perspectives

  2017cites this paper
• Bis-picolinamide Ruthenium(III) Dihalide Complexes: Dichloride-to-Diiodide Exchange Generates Single trans Isomers with High Potency and Cancer Cell Selectivity.

  2017cites this paper
• An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2

  2017cites this paper
• Synthesis, characterisation and in vitro cytotoxicity of mixed ligand Pt(ii) oxadiazoline complexes with hexamethylenetetramine and 7-nitro-1,3,5-triazaadamantane.

  2017cites this paper
• The reactivity of trans-diiodoplatinum(II) complexes containing five and six-membered N-heterocycle ligands toward some diphosphine ligands

  2017cites this paper
• Trans-platinum(II)/(IV) Complexes with Acetylpyridine Ligands as Antivascular Agents in vitro: Cytotoxic and Antiangiogenic Potential.

  2016cites this paper
• CIRCUMVENTING CISPLATIN RESISTANCE IN OVARIAN CANCERS THROUGH REACTIVATION OF p53 BY NON-CROSS-RESISTANT PLATINUM ANALOGS

  2016cites this paper
• Water-Soluble Platinum(II) Complexes Featuring 2-Alkyl-2H-tetrazol-5-ylacetic Acids: Synthesis, Characterization, and Antiproliferative Activity

  2016cites this paper
• Solvent-Triggered Cis/Trans Isomerism in Cobalt Dioxolene Chemistry: Distinguishing Effects of Packing on Valence Tautomerism.

  2016cites this paper
• The structures, cytotoxicity, apoptosis and molecular docking controlled by the aliphatic chain of palladium(II) complexes.

  2016cites this paper
• New trends in platinum and palladium complexes as antineoplastic agents

  2016cites this paper
• The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

  2016cites this paper
• Cytotoxic trans-platinum(II) complex with 3-hydroxymethylpyridine: Synthesis, X-ray structure and biological activity evaluation.

  2016cites this paper
• Development of Non-Traditional Platinum Anticancer Agents: trans-Platinum Planar Amine Compounds and Polynuclear Platinum Compounds

  2015cites this paper
• Catalytic transfer hydrogenation and anticancer activity of arene-ruthenium compounds incorporating bi-dentate precursors.

  2015cites this paper
• Metal-based Drugs

  2014cites this paper
• Synthesis, Crystal Structure, and Biological Study of PtII Complexes with 4‐Acyl‐5‐pyrazolones

  2014cites this paper
• Methylene bridge regulated geometrical preferences of ligands in cobalt(III) coordination chemistry and phenoxazinone synthase mimicking activity.

  2014cites this paper
• Characterisation of the interactions and biological impacts of cisplatin analogues and metallo-drug complexes with DNA

  2013cites this paper
• Theoretic study of DNA base guanine and adenine and protein residues’ binding mode of the trans geometries of new antitumor non-classical platinum complexes containing pyridine and picoline ligand

  2013cites this paper
• Diazido Mixed-Amine Platinum(IV) Anticancer Complexes Activatable by Visible-Light Form Novel DNA Adducts

  2013cites this paper
• Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural Factor

  2013cites this paper
• N6-Benzyladenosine Derivatives as Novel N-Donor Ligands of Platinum(II) Dichlorido Complexes

  2013cites this paper
• Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.

  2013cites this paper
• Synthetic methods for the preparation of platinum anticancer complexes.

  2013cites this paper
• Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study

  2013cites this paper
• Metal–DNA Coordination Complexes

  2013cites this paper
• Potentiometric and Thermodynamic Studies of Binary and Ternary Transition Metal(II) Complexes of Imidazole-4-acetic Acid and Some Bio-relevant Ligands

  2013cites this paper
• CYTOTOXIC PROPERTIES OF NOVEL PLATINUM COMPOUNDS, BBR3610-DACH AND TRANS-4-NBD IN TUMOR CELLS: CELLULAR EFFECTS OF 1, 2-DACH AND NBD LIGANDS

  2013cites this paper
• Antitumor trans-N-heterocyclic carbene-amine-Pt(II) complexes: synthesis of dinuclear species and exploratory investigations of DNA binding and cytotoxicity mechanisms.

  2013cites this paper
• Isomerization of platinum-coordinated iminoethers induced by spectator ligands: stabilization of the Z anti configuration.

  2013cites this paper
• Biological evaluation of transdichloridoplatinum(II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin

  2013cites this paper
• REACTIONS OF TRANS-[PtX2(pic)2] (Pic = y-PICOLINE, X = Cl-, NO3-) WITH N-ACETYL-L-CYSTEINE AND GLUTATHIONE

  2012cites this paper
• Emerging Drug Treatments for Solid Tumours

  2012cites this paper
• Reaction with DNA and pharmacologic activity of 1,10-phenanthroline and electron-rich 1,10-phenanthrocyanine complexes of d-elements

  2012cites this paper
• Cis-trans isomerism in diphenoxido bridged dicopper complexes: role of crystallized water to stabilize the cis isomer, variation in magnetic properties and conversion of both into a trinuclear species.

  2012cites this paper
• Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin

  2012cites this paper
• Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.

  2012cites this paper
• Chemical and structural biology of nucleic acids and protein-nucleic acid complexes for novel drug discovery

  2011cites this paper
• Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.

  2011cites this paper
• DNA Reactivity Profile of trans‐Platinum Planar Amine Derivatives

  2011cites this paper
• Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity.

  2011cites this paper
• Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3).

  2011cites this paper
• The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds

  2011cites this paper
• trans-Bis(3-hydroxypyridine-κN)diiodidoplatinum(II) dimethyl sulfoxide disolvate

  2011cites this paper
• Solid-phase synthesis and pharmacological evaluation of novel nucleoside-tethered dinuclear platinum(II) complexes.

  2011cites this paper
• Genotoxic effects of irinotecan combined with the novel platinum(II) complexes in human cancer cells.

  2010cites this paper
• Platinum–DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes

  2010cites this paper
• Novel cis- and trans-configured bis(oxime)platinum(II) complexes: synthesis, characterization, and cytotoxic activity.

  2010cites this paper
• Impact of the carbon chain length of novel palladium(II) complexes on interaction with DNA and cytotoxic activity.

  2010cites this paper
• Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.

  2010cites this paper
• Studies on two new mixed ligand platinum compounds with a trans-geometry.

  2010cites this paper
• Theoretical analysis of trans-[PtCl2(NH3)(thiazole)] and trans-[PtCl2(thiazole)2] binding to biological targets — Factors influence binding kinetics and adduct stability

  2010cites this paper
• Walking of antitumor bifunctional trinuclear PtII complex on double-helical DNA

  2010cites this paper
• Synthesis and anticancer activity of chalcogenide derivatives and platinum(II) and palladium(II) complexes derived from a polar ferrocene phosphanyl–carboxamide

  2010cites this paper
• Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

  2010cites this paper
• Proteins as Possible Targets for Cytotoxic trans‐Platinum(II) Complexes with Aliphatic Amine Ligands: Further Exceptions to the DNA Paradigm

  2010cites this paper
• Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines.

  2010cites this paper
• Photoactivation of trans diamine platinum complexes in aqueous solution and effect on reactivity towards nucleotides.

  2010cites this paper
• Towards Antitumor Active trans-Platinum Compounds.

  2009cites this paper
• Cytotoxic trans-oriented iminoether platinum complexes – Kinetics of binding to DNA oligonucleotides determined by 15N NMR spectroscopy

  2009cites this paper
• Unusual DNA binding modes for metal anticancer complexes.

  2009cites this paper
• Investigations using fluorescent ligands to monitor platinum(IV) reduction and platinum(II) reactions in cancer cells.

  2009cites this paper
• Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.

  2009cites this paper
• Synthesis, characterization, DNA interaction studies and anticancer activity of platinum–clotrimazole complexes

  2009cites this paper
• Status of non-classical mononuclear platinum anticancer drug development.

  2009cites this paper
• Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design

  2009cites this paper
• Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.

  2009cites this paper
• DNA bindings of a novel anticancer drug, trans-[PtCl2(isopropylamine)(3-picoline)], and kinetic competition of purine bases with protein residues in the bifunctional substitutions: a theoretical DFT study

  2009cites this paper
• Modulation of transplanaramine platinum complex reactivity by systematic modification of carrier and leaving groups

  2009cites this paper
• Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells.

  2009cites this paper
• Current development of Pd(II) complexes as potential antitumor agents.

  2009cites this paper
• Studies on New Platinum Compounds

  2009cites this paper
• Solution behavior of amidine complexes: an unexpected cis/trans isomerization and formation of di- and trinuclear platinum(III) and platinum(II) species.

  2009cites this paper
• Synthesis, activity and binding with DNA of [{trans-PtCl(NH(3))(2)}(2)micro-{trans-Pd(4-hydroxypyridine) (2) (H(2)N(CH(2))(6)NH(2))(2)]Cl(4) (TH8).

  2009cites this paper
• Trans geometry in platinum antitumor complexes

  2008cites this paper
• Comparison of cis and trans-Platinum Mononucleobase Compounds with DNA and Protein Models

  2008cites this paper
• DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects

  2008cites this paper
• Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine.

  2008cites this paper
• Synthesis and Activity of a Trinuclear Platinum Complex: [{trans‐PtCl(NH3)2}2μ‐{trans‐Pt(3‐hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in Ovarian Cancer Cell Lines

  2008cites this paper
• Biophysical studies on the stability of DNA intrastrand cross-links of transplatin.

  2008cites this paper
• Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.

  2008cites this paper